23andMe Holding Co. (ME)
USD 0.61
(0.0%)
USD 0.61
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 67.84 Million USD | -12.75% |
| 2022 | 77.76 Million USD | -0.97% |
| 2021 | 78.52 Million USD | -10.34% |
| 2020 | 87.58 Million USD | 5.89% |
| 2019 | 82.7 Million USD | -28.19% |
| 2018 | 115.18 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 65.18 Million USD | 0.0% |
| 2023 Q2 | 72.96 Million USD | -3.25% |
| 2023 Q1 | 75.41 Million USD | -3.02% |
| 2023 FY | 67.84 Million USD | -12.75% |
| 2023 Q3 | 70.44 Million USD | -3.46% |
| 2023 Q4 | 67.84 Million USD | -3.69% |
| 2022 Q1 | 76.23 Million USD | -2.91% |
| 2022 Q3 | 71.44 Million USD | -3.28% |
| 2022 Q4 | 77.76 Million USD | 8.85% |
| 2022 FY | 77.76 Million USD | -0.97% |
| 2022 Q2 | 73.86 Million USD | -3.11% |
| 2021 Q1 | 84.67 Million USD | -3.32% |
| 2021 FY | 78.52 Million USD | -10.34% |
| 2021 Q4 | 78.52 Million USD | -2.86% |
| 2021 Q3 | 80.83 Million USD | -2.1% |
| 2021 Q2 | 82.56 Million USD | -2.48% |
| 2020 Q4 | 87.58 Million USD | -1.6% |
| 2020 Q2 | - USD | 0.0% |
| 2020 FY | 87.58 Million USD | 5.89% |
| 2020 Q3 | 89 Million USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2019 FY | 82.7 Million USD | -28.19% |
| 2018 FY | 115.18 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | 3.07 Million USD | -2107.059% |
| Applied DNA Sciences, Inc. | 739.16 Thousand USD | -9078.637% |
| Aspira Women's Health Inc. | 1.43 Million USD | -4644.406% |
| Biodesix, Inc. | 35.22 Million USD | -92.605% |
| BioNexus Gene Lab Corp. | 98.76 Thousand USD | -68594.754% |
| bioAffinity Technologies, Inc. | 1.11 Million USD | -5965.887% |
| bioAffinity Technologies, Inc. | 1.11 Million USD | -5965.887% |
| Bionano Genomics, Inc. | 7.17 Million USD | -845.575% |
| CareDx, Inc | 28.27 Million USD | -139.921% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Castle Biosciences, Inc. | 14.19 Million USD | -377.849% |
| DarioHealth Corp. | 24.59 Million USD | -175.894% |
| Exact Sciences Corporation | 2.47 Billion USD | 97.259% |
| Fulgent Genetics, Inc. | 10.11 Million USD | -571.002% |
| Guardant Health, Inc. | 1.13 Billion USD | 94.049% |
| ICON Public Limited Company | 3.66 Billion USD | 98.149% |
| IDEXX Laboratories, Inc. | 622.88 Million USD | 89.108% |
| Illumina, Inc. | 1.48 Billion USD | 95.444% |
| Intelligent Bio Solutions Inc. | 81.32 Thousand USD | -83325.557% |
| iSpecimen Inc. | 29.13 Thousand USD | -232804.222% |
| Standard BioTools Inc. | 3.98 Million USD | -1603.364% |
| MDxHealth SA | 35.56 Million USD | -90.769% |
| Medpace Holdings, Inc. | 142.12 Million USD | 52.263% |
| Myriad Genetics, Inc. | 130.9 Million USD | 48.17% |
| Mainz Biomed B.V. | 2.19 Million USD | -2989.637% |
| ENDRA Life Sciences Inc. | 192.06 Thousand USD | -35224.531% |
| NeoGenomics, Inc. | 606.06 Million USD | 88.806% |
| Neogen Corporation | 888.39 Million USD | 92.363% |
| Inotiv, Inc. | 399.4 Million USD | 83.014% |
| Natera, Inc. | 282.94 Million USD | 76.022% |
| OPKO Health, Inc. | 222.03 Million USD | 69.444% |
| Psychemedics Corporation | 945 Thousand USD | -7079.365% |
| Prenetics Global Limited | 867.21 Thousand USD | -7723.319% |
| Prenetics Global Limited | 867.21 Thousand USD | -7723.319% |
| Precipio, Inc. | 106 Thousand USD | -63904.717% |
| Personalis, Inc. | 1.23 Million USD | -5397.974% |
| RadNet, Inc. | 812.06 Million USD | 91.645% |
| Sera Prognostics, Inc. | 840 Thousand USD | -7976.786% |
| Sotera Health Company | 2.22 Billion USD | 96.949% |
| Neuronetics, Inc. | 59.28 Million USD | -14.443% |
| Star Equity Holdings, Inc. | 1.14 Million USD | -5825.328% |
| Star Equity Holdings, Inc. | 1.14 Million USD | -5825.328% |
| Trinity Biotech plc | 54.65 Million USD | -24.142% |
| Twist Bioscience Corporation | 79.17 Million USD | 14.308% |
| Exagen Inc. | 19.23 Million USD | -252.79% |